CVS Agrees to Pay $315 Million to Settle DOJ Opioid Prescription Allegations

CVS Health has agreed to pay $315 million to the U.S. government to resolve a lawsuit that alleged the pharmacy chain illegally filled opioid prescriptions and sought reimbursement from Medicare and other federal programs. The Department of Justice (DOJ) brought the case in December 2024, and the settlement was announced on Tuesday. CVS did not admit wrongdoing as part of the agreement, but it will face new oversight measures.

The DOJ claimed that from October 2013 to December 2025, CVS filled prescriptions for opioids and other controlled substances that were unnecessary and in excessive amounts, violating the Controlled Substances Act and the False Claims Act. It also alleged that the company sought payment for these prescriptions from Medicare and other federal health insurance programs.

The lawsuit further alleged that CVS filled prescriptions too early, supplied “trinity” prescriptions that combine an opioid with a benzodiazepine and a muscle relaxant, and filled prescriptions from illegal pill mills. It also said that corporate policies and incentive programs prioritized profits over patient safety, influencing staffing protocols and performance metrics.

Under the settlement, CVS must establish a hotline that allows employees and the public to report suspected illegal dispensing of controlled substances, and it must proactively monitor dispensing behavior at its pharmacies. The company also agreed to monitor drug dispensing patterns and report findings to the DOJ, as part of the oversight required to protect patients and federal programs.

CVS said it strongly disagrees with the allegations and that its pharmacists are trained on safe medication use. The company stated that the settlement does not constitute an admission of wrongdoing and that it has implemented best‑in‑class programs to help pharmacists make appropriate decisions.

The DOJ’s Associate Attorney General, Stanley Woodward Jr., said the settlement is a significant milestone in the agency’s effort to combat the opioid epidemic and hold pharmacies accountable for unlawful dispensing. He added that the agreement will improve safety for Americans.

The opioid crisis has claimed nearly 80,000 lives in 2023, a ten‑fold increase since 1999, and the U.S. has paid more than $58 billion in settlements to drug companies, distributors, and retailers for related claims. CVS has previously paid $5 billion to settle other lawsuits alleging it mishandled opioid prescriptions.